These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3739647)

  • 1. Spironolactone in the treatment of hirsutism.
    Chapman MG; Katz M; Dowsett M; Hague W; Jeffcoate SL; Dewhurst CJ
    Acta Obstet Gynecol Scand; 1986; 65(4):349-50. PubMed ID: 3739647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
    Lumachi F; Rondinone R
    Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
    Erenus M; Yücelten D; Durmuşoğlu F; Gürbüz O
    Fertil Steril; 1997 Dec; 68(6):1000-3. PubMed ID: 9418687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
    Chapman MG; Dowsett M; Dewhurst CJ; Jeffcoate SL
    Br J Obstet Gynaecol; 1985 Sep; 92(9):983-5. PubMed ID: 4041402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of Aldactone and Diane in the treatment of hirsutism.
    Lunde O; Djøseland O
    J Steroid Biochem; 1987 Aug; 28(2):161-5. PubMed ID: 3626553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E; Janni A; Lobo RA
    J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of short term canrenone treatment in idiopathic hirsutism.
    Sobbrio GA; Granata A; Panacea A; Trimarchi F
    Minerva Endocrinol; 1989; 14(2):105-8. PubMed ID: 2761494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.